image imagewidth (px) 153 979 | markdown stringlengths 88 22.6k |
|---|---|
<table border="1" class="dataframe">
<tr>
<th>
Characteristic
</th>
<th>
Cases (n = 1125)
</th>
<th>
Controls (n = 1197)
</th>
<th>
P-valuea
</th>
</tr>
<tr>
<td>
Demographic factors
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>
Age (years [mean ± SD])
... | |
<table border="1" class="dataframe">
<tr>
<th>
Stratified variable (by median)
</th>
<th colspan="6">
MnSOD genotypes
</th>
</tr>
<tr>
<th>
</th>
<th colspan="2">
Val/Val
</th>
<th colspan="2">
Val/Ala
</th>
<th colspan="2">
Ala/Ala
</th>
</tr>
<tr>
<th>
</th>
<th>
n... | |
<table border="1" class="dataframe">
<tr>
<th>
Protein
</th>
<th>
Percentage
</th>
</tr>
<tr>
<td>
PCNA
</td>
<td>
15.93 ± 4.38
</td>
</tr>
<tr>
<td>
hMLH1
</td>
<td>
0.25 ± 1.11
</td>
</tr>
<tr>
<td rowspan="2">
hPMS1 in
</td>
<td>
0.6 ± 0.99
</td>
</tr>
... | |
<table border="1" class="dataframe">
<tr>
<th>
Group
</th>
<th>
RNA source
</th>
<th>
Treatment
</th>
<th>
Days after injection
</th>
<th>
No. of animals
</th>
</tr>
<tr>
<td>
AN
</td>
<td>
Naive control (absolute negative) BALB/cSCID paw
</td>
<td>
None
</td>
... | |
<table border="1" class="dataframe">
<tr>
<th>
</th>
<th colspan="2">
Mean fluorescence of CXCR3a
</th>
<th>
</th>
</tr>
<tr>
<th>
Patient no.
</th>
<th>
In PB cells
</th>
<th>
In SF cells
</th>
<th>
D/sb
</th>
</tr>
<tr>
<td>
1
</td>
<td>
35.79
</td>
<td>... | |
<table border="1" class="dataframe">
<tr>
<th>
Course
</th>
<th>
No. of patients
</th>
<th>
Age (years)
</th>
<th>
Disease duration (years)
</th>
<th>
No. of joints with active/ limited range of motion
</th>
<th>
PGI
</th>
<th>
ESR (mm/h)
</th>
<th>
Treatment; n
... | |
<table border="1" class="dataframe">
<tr>
<th>
Patient no.
</th>
<th>
Age (year)
</th>
<th>
Form
</th>
<th>
Pattern
</th>
<th>
CD3
</th>
<th colspan="3">
CCR7
</th>
<th colspan="3">
CXCR3
</th>
<th colspan="3">
CCR5
</th>
</tr>
<tr>
<th>
</th>
<th>
</th... | |
<table border="1" class="dataframe">
<tr>
<th>
</th>
<th>
</th>
<th>
</th>
<th colspan="2">
100 × CD4+CD25+/CD4+ (N)
</th>
</tr>
<tr>
<th>
Treatment
</th>
<th>
Expt no.
</th>
<th>
Organ
</th>
<th>
IFN-γR KO
</th>
<th>
WT
</th>
</tr>
<tr>
<td rowspan="6">
N... | |
<table border="1" class="dataframe">
<tr>
<th rowspan="2">
SAGE library
</th>
<th rowspan="2">
Total testis TT 1+2
</th>
<th rowspan="2">
Adult testis somatic cells ATSC
</th>
</tr>
<tr>
</tr>
<tr>
<td>
Total tags
</td>
<td>
76 854
</td>
<td>
81 478
</td>
</tr>
<tr>
<t... | |
<table border="1" class="dataframe">
<tr>
<th>
Predicted
</th>
<th>
Observed
</th>
<th>
N of observations
</th>
</tr>
<tr>
<td>
0.001
</td>
<td>
0.001
</td>
<td>
1116
</td>
</tr>
<tr>
<td>
0.010
</td>
<td>
0.007
</td>
<td>
2621
</td>
</tr>
<tr>
<td... | |
<table border="1" class="dataframe">
<tr>
<th>
Level of Evidence
</th>
<th>
Preventive Manoeuvre
</th>
</tr>
<tr>
<td rowspan="8">
AΩ & B¥-categories: (Appropriate)
</td>
<td>
1. Folic acid for primary prevention of neural tube defects
</td>
</tr>
<tr>
<td>
2. Smoking cessation... | |
<table border="1" class="dataframe">
<tr>
<th>
Measure
</th>
<th>
Intervention Group (N = 22)
</th>
<th>
Control Group (N = 23)
</th>
<th>
Significance (P value)
</th>
</tr>
<tr>
<td>
Percentage of Group Practices
</td>
<td>
77.3%
</td>
<td>
60.9%
</td>
<td>
.34
... | |
<table border="1" class="dataframe">
<tr>
<th>
Variable
</th>
<th>
Value and Rangea
</th>
<th>
Source
</th>
</tr>
<tr>
<td>
A & B Manœuvres
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>
Folic Acid
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>
Difference in ... | |
<table border="1" class="dataframe">
<tr>
<th>
Variable
</th>
<th>
Value and Rangea
</th>
<th>
Source
</th>
</tr>
<tr>
<td>
D Manoeuvres
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>
Blood Glucose Screening
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>
Differen... | |
<table border="1" class="dataframe">
<tr>
<th>
Condition
</th>
<th>
Baseline
</th>
<th>
Low
</th>
<th>
High
</th>
</tr>
<tr>
<td>
Breast Cancer
</td>
<td>
$12,075.20
</td>
<td>
$4,026.97
</td>
<td>
$20,123.44
</td>
</tr>
<tr>
<td>
Influenza
</td>
<td... | |
<table border="1" class="dataframe">
<tr>
<th>
</th>
<th>
Baseline
</th>
<th>
Low
</th>
<th>
High
</th>
</tr>
<tr>
<td>
Costs
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>
Intervention Cost
</td>
<td>
$238,388
</td>
<td>
$238,388
</td>
<td... | |
<table border="1" class="dataframe">
<tr>
<th>
Purpose
</th>
<th>
Family Medicine [%]
</th>
<th>
Specialist [%]
</th>
<th>
χ2
</th>
<th>
df
</th>
<th>
p-value
</th>
</tr>
<tr>
<td>
Personal use
</td>
<td>
83.0
</td>
<td>
86.4
</td>
<td>
3.87
</td>... | |
<table border="1" class="dataframe">
<tr>
<th colspan="2">
Percentiles
</th>
<th colspan="2">
Boys
</th>
<th colspan="2">
Girls
</th>
</tr>
<tr>
<th>
</th>
<th>
</th>
<th>
Q-max
</th>
<th>
Q-Ave
</th>
<th>
Q-max
</th>
<th>
Q-Ave
</th>
</tr>
<tr>
<td rowspa... | |
<table border="1" class="dataframe">
<tr>
<th>
Scale
</th>
<th colspan="6">
Scale statistics
</th>
</tr>
<tr>
<th>
</th>
<th>
Mean (SD) Total UK Sample
</th>
<th>
Mean (SD) Total US Sample
</th>
<th>
Percentage floor chronic health condition/healthy (UK Sample)
</th>
<th>
... | |
<table border="1" class="dataframe">
<tr>
<th>
Scale
</th>
<th colspan="4">
Self-report
</th>
<th colspan="4">
Proxy-report
</th>
</tr>
<tr>
<th>
</th>
<th>
N
</th>
<th>
Mean (sd)
</th>
<th>
df
</th>
<th>
F
</th>
<th>
N
</th>
<th>
Mean (sd)
</th>
<... | |
<table border="1" class="dataframe">
<tr>
<th>
Scale:
</th>
<th>
Total Sample
</th>
<th>
Healthy children
</th>
<th>
Children with chronic health condition
</th>
</tr>
<tr>
<td>
Total score
</td>
<td>
0.56*
</td>
<td>
0.32*
</td>
<td>
0.67*
</td>
</tr>
<tr>
... | |
<table border="1" class="dataframe">
<tr>
<th>
Base Model
</th>
<th>
Spatial Distribution Function of Alternative Model
</th>
<th>
Base Model Observed Dataset
</th>
<th>
More Explicit Model Observed Dataset
</th>
</tr>
<tr>
<td>
Null
</td>
<td>
Distance Decline
</td>
<td>
... | |
<table border="1" class="dataframe">
<tr>
<th>
Author
</th>
<th>
Year
</th>
<th>
No of cases
</th>
<th>
Results
</th>
</tr>
<tr>
<td>
Zahner et al [15]
</td>
<td>
1994
</td>
<td>
1
</td>
<td>
Positive
</td>
</tr>
<tr>
<td>
Cadigan et al [7]
</td>
<td... | |
<table border="1" class="dataframe">
<tr>
<th>
Time (h)
</th>
<th>
Type
</th>
<th colspan="5">
Duration
</th>
<th>
Time (h)
</th>
<th colspan="5">
Duration
</th>
</tr>
<tr>
<th>
</th>
<th>
</th>
<th colspan="2">
Oscillation type
</th>
<th colspan="2">
Fetal move... | |
<table border="1" class="dataframe">
<tr>
<th>
Sitea
</th>
<th>
Enzymeb
</th>
<th>
Gene Card
</th>
<th>
UniGenec
</th>
<th>
SAGEc
</th>
<th>
Full Name
</th>
</tr>
<tr>
<td rowspan="4">
163
</td>
<td>
EGFR Kinase
</td>
<td>
EGFR
</td>
<td>
Yes
</td... | |
<table border="1" class="dataframe">
<tr>
<th>
</th>
<th>
Nature (12/00)
</th>
<th>
Release 1 (8/01)
</th>
<th>
Release 2 (1/02)
</th>
<th>
Release 3 (8/02)
</th>
<th>
Release 4 (4/03)
</th>
<th>
Release 5 (1/04)
</th>
</tr>
<tr>
<td>
Genome size (Mb)
</td>
<td>... | |
<table border="1" class="dataframe">
<tr>
<th>
Transposable element classification
</th>
<th>
# Annotated genomic regions
</th>
</tr>
<tr>
<td>
Class I (Retrotransposons)
</td>
<td>
1652
</td>
</tr>
<tr>
<td>
gypsy-like retrotransposon family (Athila)
</td>
<td>
511
</td>
... | |
<table border="1" class="dataframe">
<tr>
<th>
Amino Acid
</th>
<th>
Overall composition
</th>
<th>
All Genes (3462)
</th>
<th>
Proteins (>100 residues)
</th>
<th>
Membrane Proteins
</th>
<th>
Non-Membrane Proteins
</th>
</tr>
<tr>
<td>
A
</td>
<td>
5.49
</t... | |
<table border="1" class="dataframe">
<tr>
<th>
Method
</th>
<th>
FP
</th>
<th>
FN
</th>
<th>
TP
</th>
<th>
TN
</th>
<th>
S(M)
</th>
</tr>
<tr>
<td>
GEM
</td>
<td>
4
</td>
<td>
6
</td>
<td>
115
</td>
<td>
2340
</td>
<td>
226
</td>
</... | |
<table border="1" class="dataframe">
<tr>
<th>
Percent Composition
</th>
<th colspan="2">
Ala
</th>
<th colspan="2">
Gly
</th>
<th colspan="2">
Arg
</th>
<th colspan="2">
Val
</th>
</tr>
<tr>
<th>
</th>
<th>
Genes *
</th>
<th>
E. Level **
</th>
<th>
Genes
<... | |
<table border="1" class="dataframe">
<tr>
<th>
Percent Composition
</th>
<th colspan="2">
Asp
</th>
<th colspan="2">
Leu
</th>
<th colspan="2">
Asn
</th>
<th colspan="2">
Ser
</th>
</tr>
<tr>
<th>
</th>
<th>
Genes*
</th>
<th>
E. Level**
</th>
<th>
Genes
</t... | |
<table border="1" class="dataframe">
<tr>
<th>
Amino Acid
</th>
<th colspan="2">
Alternate Dataset 1 (Untreated)
</th>
<th colspan="2">
Alternate Dataset 2 (Treated)
</th>
</tr>
<tr>
<th>
</th>
<th>
All Genes
</th>
<th>
> 100 residues
</th>
<th>
All Genes
</th>
<th>... | |
<table border="1" class="dataframe">
<tr>
<th>
Amino Acid
</th>
<th>
Correlation with log(Fold change)
</th>
</tr>
<tr>
<td>
A
</td>
<td>
-0.184
</td>
</tr>
<tr>
<td>
C
</td>
<td>
0.055
</td>
</tr>
<tr>
<td>
D
</td>
<td>
0.029
</td>
</tr>
<tr>
<td>
E... | |
<table border="1" class="dataframe">
<tr>
<th>
</th>
<th colspan="2">
Total Samples
</th>
<th colspan="2">
Scanty Growth
</th>
<th colspan="2">
Semi-confluent growth
</th>
<th colspan="2">
Confluent growth
</th>
<th>
P-value2
</th>
</tr>
<tr>
<th>
Nugent's score1
</th>
... | |
<table border="1" class="dataframe">
<tr>
<th>
Genital micro-organisms
</th>
<th colspan="7">
Prevalence of genital micro-organism in those with:
</th>
</tr>
<tr>
<th>
</th>
<th colspan="2">
No lactobacilli
</th>
<th colspan="2">
Non H2O2 producing lactobacilli
</th>
<th colspan="2"... | |
<table border="1" class="dataframe">
<tr>
<th>
</th>
<th colspan="3">
Prevalence of BV (Nugent's score 7–10)
</th>
<th colspan="3">
Prevalence of HIV
</th>
</tr>
<tr>
<th>
</th>
<th>
n/N
</th>
<th>
%
</th>
<th>
P-value4
</th>
<th>
n/N
</th>
<th>
%
</th>
<th>... | |
<table border="1" class="dataframe">
<tr>
<th>
Season
</th>
<th>
Onset
</th>
<th>
Peak
</th>
<th>
Offset
</th>
<th>
Duration
</th>
</tr>
<tr>
<td>
1995/1996 late season
</td>
<td>
1
</td>
<td>
12
</td>
<td>
17
</td>
<td>
17
</td>
</tr>
<tr>
<t... | |
<table border="1" class="dataframe">
<tr>
<th>
Gene
</th>
<th>
No. of Species
</th>
<th>
TP
</th>
<th>
TN
</th>
<th>
FP
</th>
<th>
FN
</th>
<th>
Specificity
</th>
<th>
Sensitivity
</th>
<th>
Accuracy
</th>
<th>
Balanced Accuracy
</th>
</tr>
<tr>
... | |
<table border="1" class="dataframe">
<tr>
<th>
Gene
</th>
<th>
Species
</th>
<th>
TP
</th>
<th>
FP
</th>
<th>
FN
</th>
<th>
Score
</th>
</tr>
<tr>
<td>
atp1
</td>
<td>
Secale cereale
</td>
<td>
0
</td>
<td>
5
</td>
<td>
1 (0)
</td>
<td>
... | |
<table border="1" class="dataframe">
<tr>
<th>
Mantoux
</th>
<th>
Children
</th>
<th colspan="3">
Evaluation of scar formation [n (%)]
</th>
</tr>
<tr>
<th>
Induration (mm)
</th>
<th>
n
</th>
<th>
Real scar (>2 mm)
</th>
<th>
(≤ Tiny scar 2 mm)
</th>
<th>
No s... | |
<table border="1" class="dataframe">
<tr>
<th>
Method
</th>
<th>
ref1
</th>
<th>
ref2
</th>
<th>
ref3
</th>
<th>
Total
</th>
</tr>
<tr>
<td>
DIALIGN-T
</td>
<td>
82.28%
</td>
<td>
78.36%
</td>
<td>
79.71%
</td>
<td>
80.12%
</td>
</tr>
<tr>
<td... | |
<table border="1" class="dataframe">
<tr>
<th>
Method
</th>
<th>
ref1
</th>
<th>
ref2
</th>
<th>
ref3
</th>
<th>
ref4
</th>
<th>
ref5
</th>
<th>
Total
</th>
</tr>
<tr>
<td>
DIALIGN-T
</td>
<td>
82.76%
</td>
<td>
91.28%
</td>
<td>
75.34%
</t... | |
<table border="1" class="dataframe">
<tr>
<th>
Method
</th>
<th>
ref1
</th>
<th>
ref2
</th>
<th>
ref3
</th>
<th>
Total
</th>
</tr>
<tr>
<td>
DIALIGN 2.2
</td>
<td>
20.00%+
</td>
<td>
23.33%0
</td>
<td>
23.33%+
</td>
<td>
22.22%+
</td>
</tr>
<tr>... | |
<table border="1" class="dataframe">
<tr>
<th>
Method
</th>
<th>
ref1
</th>
<th>
ref2
</th>
<th>
ref3
</th>
<th>
Total
</th>
</tr>
<tr>
<td>
DIALIGN 2.2
</td>
<td>
11.67%+
</td>
<td>
21.67%0
</td>
<td>
23.33%+
</td>
<td>
18.89%+
</td>
</tr>
<tr>... | |
<table border="1" class="dataframe">
<tr>
<th>
Pfam
</th>
<th>
Type
</th>
<th>
SCOP
</th>
</tr>
<tr>
<td>
DHH
</td>
<td>
Family
</td>
<td>
c.107.1.1; c.107.1.2
</td>
</tr>
<tr>
<td>
OsmC
</td>
<td>
Family
</td>
<td>
d.227.1.2; d.227.1.1
</td>
</tr>
<... | |
<table border="1" class="dataframe"><tr><td>Signs and symptoms of HF</td><td>Effort dyspnoea, Hortopnoea, III-IV tones, Pulmonary rales</td></tr><tr><td>Normal or mildly reduced LV systolic function</td><td>≥ EF 45 % e LVIDDi > 3.2 cm·m -2</td></tr><tr><td>Evidence of abnormalities LV of relaxation/filling and/or di... | |
<table border="1" class="dataframe">
<tr>
<th>
Event
</th>
<th colspan="2">
Happened to Me
</th>
<th colspan="2">
Happened to Someone I Know Well
</th>
</tr>
<tr>
<th>
</th>
<th>
Number
</th>
<th>
%
</th>
<th>
Number
</th>
<th>
%
</th>
</tr>
<tr>
<td>
Badly... | |
<table border="1" class="dataframe">
<tr>
<th colspan="2">
Rate of PTSD symptoms on the K-SADS
</th>
<th colspan="2">
Rate of PTSD symptoms on the CATS
</th>
</tr>
<tr>
<th>
symptom
</th>
<th>
%
</th>
<th>
symptom
</th>
<th>
%
</th>
</tr>
<tr>
<td>
</td>
<td colspan=... | |
<table border="1" class="dataframe">
<tr>
<th>
PTSD Symptom
</th>
<th>
</th>
<th>
</th>
<th>
</th>
<th colspan="2">
95% Confidence Interval
</th>
</tr>
<tr>
<th>
</th>
<th>
</th>
<th>
Observed Kappa
</th>
<th>
Standard Error
</th>
<th>
Lower Limit
</th>
<th>
... | |
<table border="1" class="dataframe">
<tr>
<th>
</th>
<th rowspan="3">
Interested (n = 225) %
</th>
<th rowspan="3">
Non-interested (n = 553) %
</th>
<th rowspan="3">
OR (95% CI)1)
</th>
</tr>
<tr>
<th>
</th>
</tr>
<tr>
<th>
</th>
</tr>
<tr>
<td>
Physician visit in past year
... | |
<table border="1" class="dataframe">
<tr>
<th>
Complication
</th>
<th>
Patients (n)
</th>
</tr>
<tr>
<td>
Pin site infection grade 2 [13]
</td>
<td>
5
</td>
</tr>
<tr>
<td>
Loose pin at removal of fixator/pins
</td>
<td>
6
</td>
</tr>
<tr>
<td>
Septic arthritis
</... | |
<table border="1" class="dataframe">
<tr>
<th>
</th>
<th colspan="5">
Univeriate analysis
</th>
<th colspan="3">
Multivariate analysisII
</th>
</tr>
<tr>
<th>
Predictor Variable
</th>
<th>
Na
</th>
<th>
Cb
</th>
<th>
(95% CI)
</th>
<th>
pc
</th>
<th>
R2 adjd
... | |
<table border="1" class="dataframe">
<tr>
<th>
Characteristics
</th>
<th colspan="5">
Income Quintile
</th>
<th>
P-value
</th>
</tr>
<tr>
<th>
</th>
<th>
1
</th>
<th>
2
</th>
<th>
3
</th>
<th>
4
</th>
<th>
5
</th>
<th>
</th>
</tr>
<tr>
<td>
</td>
... | |
<table border="1" class="dataframe">
<tr>
<th>
Outcome/Treatment N (%)
</th>
<th colspan="5">
Income Quintile
</th>
<th>
P-value
</th>
</tr>
<tr>
<th>
</th>
<th>
1
</th>
<th>
2
</th>
<th>
3
</th>
<th>
4
</th>
<th>
5
</th>
<th>
</th>
</tr>
<tr>
<td>
... | |
<table border="1" class="dataframe">
<tr>
<th>
Season correlated with malaria cases in 1800–1870
</th>
<th colspan="4">
Source of temperature series
</th>
</tr>
<tr>
<th>
</th>
<th>
Helsinki 1830–1870 41 years
</th>
<th>
Tornedalen 1818–1870 53 years
</th>
<th>
Stockholm 1800–187... | |
<table border="1" class="dataframe">
<tr>
<th>
Month of preceding year correlated with malaria cases in 1800–1870
</th>
<th colspan="4">
Source of temperature series
</th>
</tr>
<tr>
<th>
</th>
<th>
Helsinki 1830–1870 41 years
</th>
<th>
Tornedalen 1818–1870 53 years
</th>
<th>
S... | |
<table border="1" class="dataframe">
<tr>
<th>
Tortoise no.
</th>
<th colspan="20">
Nucleotide position
</th>
<th>
Origin
</th>
<th>
12S haplotype
</th>
</tr>
<tr>
<th>
</th>
<th>
</th>
<th>
</th>
<th>
</th>
<th>
</th>
<th>
1
</th>
<th>
1
</th>
<th>
... | |
<table border="1" class="dataframe">
<tr>
<th>
A.
</th>
<th colspan="12">
HPV cLIA time (weeks)
</th>
</tr>
<tr>
<th>
HPV type
</th>
<th>
0
</th>
<th>
2
</th>
<th>
4
</th>
<th>
8
</th>
<th>
10
</th>
<th>
12
</th>
<th>
16
</th>
<th>
20
</th>... | |
<table border="1" class="dataframe">
<tr>
<th>
Index
</th>
<th>
N
</th>
<th colspan="2">
Groups
</th>
<th>
P < :
</th>
</tr>
<tr>
<th>
</th>
<th>
</th>
<th>
Control (+/+)
</th>
<th>
Diabetes (db/db)
</th>
<th>
</th>
</tr>
<tr>
<td>
Body Weight (g)
</t... | |
<table border="1" class="dataframe">
<tr>
<th>
Source of E. coli
</th>
<th>
Lambda
</th>
<th>
M13
</th>
<th>
P1
</th>
<th>
øX174
</th>
<th>
T4
</th>
<th>
T7
</th>
<th>
none
</th>
</tr>
<tr>
<td>
Mouse feces and GI tracts (n = 22)
</td>
<td>
0 (0%)
... | |
<table border="1" class="dataframe">
<tr>
<th>
Study Group
</th>
<th>
No.
</th>
<th>
11
</th>
<th>
12
</th>
<th>
22
</th>
<th colspan="3">
12 + 22
</th>
</tr>
<tr>
<th>
</th>
<th>
</th>
<th>
n (%)
</th>
<th>
n (%)
</th>
<th>
n (%)
</th>
<th>
... | |
<table border="1" class="dataframe">
<tr>
<th>
Functional type
</th>
<th>
Fluffy tails (F>2)
</th>
<th>
No fluffy tails (F<2)
</th>
<th>
Positive rate
</th>
<th>
Negative rate
</th>
</tr>
<tr>
<td>
Regulatory regions
</td>
<td>
51
</td>
<td>
9
</td>
<td... | |
<table border="1" class="dataframe">
<tr>
<th>
</th>
<th>
Arabidopsis thaliana
</th>
<th>
Haemophilus influenzae
</th>
<th>
Helicobacter pylori 26695
</th>
<th>
Helicobacter pylori J99
</th>
<th>
Homo sapien
</th>
<th>
Saccharomyces cerevisiae
</th>
</tr>
<tr>
<td>
... | |
<table border="1" class="dataframe">
<tr>
<th>
</th>
<th>
14,349 Unique NCBI One Term Windows
</th>
<th>
18,934 Unique NCBI Two Term Windows
</th>
<th>
24,747 Unique NCBI Three Term Windows
</th>
</tr>
<tr>
<td>
GO Term Equality
</td>
<td>
16,001
</td>
<td>
9096
</td>
... | |
<table border="1" class="dataframe">
<tr>
<th>
Characteristics
</th>
<th>
Stage I
</th>
<th>
Stage II
</th>
<th>
Stage III
</th>
<th>
Stage IV
</th>
<th>
P value
</th>
</tr>
<tr>
<td>
Age at Cohort Entrance
</td>
<td>
14.3 ± 2.3
</td>
<td>
15.4 ± 2.9
</t... | |
<table border="1" class="dataframe">
<tr>
<th>
Level of clinical suspicion
</th>
<th>
Ultrasound
</th>
<th>
No Ultrasound
</th>
<th>
Risk ratio for harm (95% CI)
</th>
<th>
Risk ratio for benefit (95% CI)
</th>
<th>
Odds ratio (95% CI)
</th>
<th>
Risk difference (95% CI)
... | |
<table border="1" class="dataframe">
<tr>
<th>
</th>
<th>
PSZ threshold
</th>
<th>
# phylogenetic motifs
</th>
<th>
# sequences
</th>
</tr>
<tr>
<td>
# phylogenetic motifs
</td>
<td>
0.15
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>
# sequences
</td>
<td>
0... | |
<table border="1" class="dataframe">
<tr>
<th>
Protein family
</th>
<th>
PDB ID
</th>
<th>
Correct
</th>
<th>
Useful info
</th>
<th>
Wrong
</th>
</tr>
<tr>
<td>
A. Proteins from Table 1
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>
... | |
<table border="1" class="dataframe">
<tr>
<th>
Age of the patienta
</th>
<th>
Detected pathogenic microbial strain(s)
</th>
<th>
Antimicrobial agent(s) used
</th>
<th>
Special remarks
</th>
</tr>
<tr>
<td>
11 months
</td>
<td>
E. coli (group C)
</td>
<td>
Trimethoprim a... | |
<table border="1" class="dataframe">
<tr>
<th colspan="2">
Threshold of clinical benefit that would make offering PDT as a treatment worthwhile
</th>
<th colspan="4">
Survey year
</th>
</tr>
<tr>
<th>
</th>
<th>
</th>
<th>
2000
</th>
<th>
2001
</th>
<th>
2002
</th>
<th>
... | |
<table border="1" class="dataframe">
<tr>
<th>
Dependent variable
</th>
<th>
Independent variables
</th>
<th>
β
</th>
<th>
R
</th>
<th>
R2
</th>
<th>
Adjusted R2
</th>
</tr>
<tr>
<td rowspan="5">
Attitude concerning the use of PDT
</td>
<td>
Social pressure from ... | |
<table border="1" class="dataframe">
<tr>
<th>
Characteristic
</th>
<th colspan="6">
Genotype [n (%)]
</th>
</tr>
<tr>
<th>
</th>
<th>
CYP2D6*1/*1
</th>
<th>
CYP2D6*1/*4
</th>
<th>
CYP2D6*4/*4
</th>
<th>
SULT1A1*1/*1
</th>
<th>
SULT1A1*1/*2
</th>
<th>
SULT1A1... | |
<table border="1" class="dataframe">
<tr>
<th>
Clone
</th>
<th>
Monkey
</th>
<th>
Longest time to Syncytia Formation
</th>
<th>
Longest time to Detectable p27
</th>
</tr>
<tr>
<td>
Group 1
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>
109
</td>
<td>
... | |
<table border="1" class="dataframe">
<tr>
<th>
Env – gp41
</th>
<th>
573
</th>
<th>
631
</th>
<th>
676
</th>
<th>
713
</th>
<th>
734
</th>
<th>
737
</th>
<th>
741
</th>
<th>
751
</th>
<th>
752
</th>
<th>
760
</th>
<th>
764
</th>
<th>... | |
<table border="1" class="dataframe">
<tr>
<th>
</th>
<th>
695
</th>
<th>
737
</th>
<th>
741
</th>
<th>
747
</th>
<th>
748
</th>
<th>
751
</th>
<th>
758
</th>
<th>
760
</th>
<th>
785
</th>
<th>
794
</th>
<th>
802
</th>
<th>
808
</th... | |
<table border="1" class="dataframe">
<tr>
<th>
</th>
<th colspan="5">
Observed Unordered Genotypes/Number of A Alleles in Pool j | True Unordered Genotype AABB
</th>
</tr>
<tr>
<th>
α
</th>
<th>
BBBB/ 0
</th>
<th>
ABBB/ 1
</th>
<th>
AABB/ 2
</th>
<th>
AAAB/ 3
</th>
<th... | |
<table border="1" class="dataframe">
<tr>
<th>
Group (G)
</th>
<th>
Sample
</th>
<th>
Year
</th>
<th>
n
</th>
<th>
Age years mean (SD)
</th>
<th>
Sex % males
</th>
<th>
Education median level (range)
</th>
</tr>
<tr>
<td>
1
</td>
<td>
First population samp... | |
<table border="1" class="dataframe">
<tr>
<th>
Variable
</th>
<th>
OR (CI)
</th>
</tr>
<tr>
<td>
Psychological illness low
</td>
<td>
1
</td>
</tr>
<tr>
<td>
High
</td>
<td>
2.2 (1.2–4.0)
</td>
</tr>
<tr>
<td>
Abdominal illness low
</td>
<td>
1
</td>
</tr>... | |
<table border="1" class="dataframe">
<tr>
<th colspan="2">
N = 43
</th>
</tr>
<tr>
<th>
Retrospective
</th>
<th>
7
</th>
</tr>
<tr>
<td>
Planning
</td>
<td>
4
</td>
</tr>
<tr>
<td>
Not in 3rd trimester
</td>
<td>
32
</td>
</tr>
<tr>
<td>
Discontinued drug (... | |
<table border="1" class="dataframe">
<tr>
<th rowspan="3">
Bronchus Superficial Epithelium Basal Cells
</th>
<th rowspan="3">
AQP5 (Apical), AQP4 (Basolateral) AQP3
</th>
</tr>
<tr>
</tr>
<tr>
</tr>
<tr>
<td>
Submucosal Glands
</td>
<td>
AQP5 (Apical), AQP3,4 (Basolateral)
</td>
</tr... | |
<table border="1" class="dataframe">
<tr>
<th>
</th>
<th>
B
</th>
<th>
S.E.
</th>
<th>
Wald
</th>
<th>
df
</th>
<th>
Sig.
</th>
<th>
Odds ratio Exp(B) (90% C.I.)
</th>
</tr>
<tr>
<td>
INITIAL MODEL*
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>... | |
<table border="1" class="dataframe">
<tr>
<th>
CONSULTATION AT GP COOPERATIVE
</th>
<th>
B
</th>
<th>
S.E.
</th>
<th>
Wald
</th>
<th>
df
</th>
<th>
Sig.
</th>
<th>
Odds ratio Exp(B) (90% C.I.)
</th>
</tr>
<tr>
<td>
INITIAL MODEL*
</td>
<td>
</td>
<td>
<... | |
<table border="1" class="dataframe">
<tr>
<th>
</th>
<th>
Ka, M-1
</th>
<th>
-∆H, kcal/mole
</th>
<th>
-∆G, kcal/mole
</th>
<th>
-∆S, cal/moleK
</th>
<th>
Nr exp.
</th>
</tr>
<tr>
<td>
27°C
</td>
<td>
192 ± 5
</td>
<td>
6.27 ± 0.10
</td>
<td>
3.122
<... | |
<table border="1" class="dataframe">
<tr>
<th>
Treatment
</th>
<th colspan="5">
Response (%)
</th>
</tr>
<tr>
<th>
</th>
<th>
N
</th>
<th>
Complete
</th>
<th>
Partial
</th>
<th>
Death or peritoneal metastasis
</th>
<th>
None
</th>
</tr>
<tr>
<td>
Ad.p35 + A... | |
<table border="1" class="dataframe">
<tr>
<th>
</th>
<th>
DA sample (N = 60)
</th>
<th>
Historical controls (No./Total)
</th>
<th>
Fisher's Exact Test P-value
</th>
</tr>
<tr>
<td>
Knowledge of personal pathology results
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
... | |
<table border="1" class="dataframe"><tr><td>Amount of information</td><td>Much less than needed 5%</td><td>A little less than needed 14%</td><td>About right 77%</td><td>A little more than needed 4%</td><td></td><td>DK or refused 7%</td></tr><tr><td>Length</td><td>Much too short 0%</td><td>A little too short 11%</td><td... | |
<table border="1" class="dataframe">
<tr>
<th>
Surgical complications
</th>
<th>
General complications
</th>
<th>
Perioperative Mortality
</th>
</tr>
<tr>
<td>
Surgical procedure (p = 0.0004)
</td>
<td>
Surgical procedure (p = 0.0001)
</td>
<td>
Surgical procedure (p = 0.0068)... | |
<table border="1" class="dataframe">
<tr>
<th>
parameter
</th>
<th>
Squamous cell carcinoma (n = 229)
</th>
<th>
Adenocarcinoma (n = 150)
</th>
<th>
p-value
</th>
</tr>
<tr>
<td>
- Surgical procedure (% transhiatal)
</td>
<td>
30.6
</td>
<td>
68.7
</td>
<td>
0.00... | |
<table border="1" class="dataframe">
<tr>
<th>
</th>
<th colspan="2">
Putative S/MARs in 5' regions (%)*
</th>
<th colspan="2">
Putative S/MARs in 3' regions (%)*
</th>
</tr>
<tr>
<th>
Prediction scheme
</th>
<th>
Hkg#
</th>
<th>
Tsg§
</th>
<th>
Hkg#
</th>
<th>
Tsg§... | |
<table border="1" class="dataframe">
<tr>
<th>
Length (bp)*
</th>
<th colspan="4">
P-value in intervals of scores
</th>
</tr>
<tr>
<th>
</th>
<th>
-1.2 to -1
</th>
<th>
-1 to -0.8
</th>
<th>
0.8 to 1
</th>
<th>
1 to 1.2
</th>
</tr>
<tr>
<td>
400
</td>
<td>
... | |
<table border="1" class="dataframe">
<tr>
<th>
Repeat category
</th>
<th colspan="2">
No. of copies
</th>
<th colspan="2">
% of the total sequences covered by the repeat
</th>
</tr>
<tr>
<th>
</th>
<th>
Hkg#
</th>
<th>
Tsg*
</th>
<th>
Hkg#
</th>
<th>
Tsg*
</th>
<... | |
<table border="1" class="dataframe">
<tr>
<th>
Unified Nomenclature
</th>
<th>
Domain
</th>
<th>
Human
</th>
<th>
S. cerevisiae (Core subunits)
</th>
<th>
S. pombe Csn7Bp complex
</th>
<th>
S. pombe Int6p complex
</th>
<th>
S. pombe eIF3b complex
</th>
</tr>
<tr>
<t... | |
<table border="1" class="dataframe">
<tr>
<th>
Name
</th>
<th colspan="2">
Genotype
</th>
<th>
Source
</th>
</tr>
<tr>
<th>
DS448/1
</th>
<th>
leu1-32 ura4-d18 ade6-704
</th>
<th>
h+
</th>
<th>
Lab stock
</th>
</tr>
<tr>
<td>
DS448/2
</td>
<td>
leu1-32 u... | |
<table border="1" class="dataframe">
<tr>
<th>
Gene Name
</th>
<th>
Sequence
</th>
<th>
Product Size (bp)
</th>
</tr>
<tr>
<td>
actinF
</td>
<td>
GAGCTTCCTGATGGTCAAGT
</td>
<td>
200
</td>
</tr>
<tr>
<td>
actinR
</td>
<td>
GGATACATAGTGGTACCACC
</td>
<td>
<... | |
<table border="1" class="dataframe">
<tr>
<th>
Class of mutants
</th>
<th>
Gene or ORF name deleted
</th>
<th>
Functional group
</th>
<th>
Response HAP in spot tests†
</th>
<th>
Induced mutant frequency (×10-7) by HAP#
</th>
<th>
Survival in presence of HAP#
</th>
</tr>
<tr>... | |
<table border="1" class="dataframe">
<tr>
<th>
Finding
</th>
<th>
BASDAI
</th>
<th>
BASMI
</th>
<th>
BASFI
</th>
<th>
PatGA
</th>
<th>
PhysGA
</th>
<th>
NRS-P
</th>
<th>
ESR (mm/h)
</th>
<th>
CRP (mg/l)
</th>
</tr>
<tr>
<td colspan="2">
At time poin... | |
<table border="1" class="dataframe">
<tr>
<th>
Parameter
</th>
<th>
RA patients (n = 8)
</th>
<th>
AC patients (n = 3)
</th>
</tr>
<tr>
<td>
Age (years)
</td>
<td>
58 (34–69)
</td>
<td>
56 (49–68)
</td>
</tr>
<tr>
<td>
Sex (no. of males/females)
</td>
<td>
4/4
... | |
<table border="1" class="dataframe">
<tr>
<th>
Origin
</th>
<th>
mAb
</th>
<th>
Synovial fluid
</th>
</tr>
<tr>
<td>
CD4+ cells
</td>
<td>
CD4
</td>
<td>
191 (<10–711)
</td>
</tr>
<tr>
<td>
CD8+ cells
</td>
<td>
CD8
</td>
<td>
<10 (<10–331)
</... | |
<table border="1" class="dataframe">
<tr>
<th>
Target
</th>
<th>
Forward primer
</th>
<th>
Probe
</th>
<th>
Reverse primer
</th>
<th>
Threshold
</th>
</tr>
<tr>
<td>
GAPDH
</td>
<td>
PDAR
</td>
<td>
PDAR
</td>
<td>
PDAR
</td>
<td>
0.047
</td>
</t... | |
<table border="1" class="dataframe">
<tr>
<th>
Target
</th>
<th>
General trend
</th>
<th colspan="2">
Tissues affected
</th>
<th>
Significant changesa (P < 0.05)
</th>
</tr>
<tr>
<th>
</th>
<th>
</th>
<th>
Origin of cells
</th>
<th>
Disease state
</th>
<th>
</... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.